BL Pharmtech Corp. Logo

BL Pharmtech Corp.

Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.

065170 | KO

Overview

Corporate Details

ISIN(s):
KR7065170003
LEI:
Country:
South Korea
Address:
경기도 용인시 수지구 신수로 767 134호(동천동, 분당수지유타워 지식산업센터), 용인시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BL Pharmtech Corp., formerly Next BT Co Ltd, is a company engaged in the health food and biotechnology sectors. Established in 1995, its primary business involves the manufacturing, distribution, import, and export of health functional foods, dietary supplements, and cosmetics. The company is also active in bio-pharmaceutical research and development, collaborating with academic institutions such as KAIST and Columbia University Medical Center through its subsidiaries, BL Melanies and BL Science. These research efforts are centered at the Daedeok Research Complex.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-07-30 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제21회차 CB)
Korean 5.6 KB
2025-07-28 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 12.8 KB
2025-07-22 00:00
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
Korean 56.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.2 MB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.5 KB
2025-03-28 00:00
Share Issue/Capital Change
전환가액의조정 (제19회차)
Korean 13.1 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 26.6 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.0 MB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.6 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 187.3 KB
2025-03-12 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.6 KB
2025-02-27 00:00
Share Issue/Capital Change
전환가액의조정
Korean 21.1 KB
2025-02-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.9 KB
2025-02-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB

Automate Your Workflow. Get a real-time feed of all BL Pharmtech Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BL Pharmtech Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BL Pharmtech Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IGC Pharma, Inc. Logo
Clinical-stage pharma creating Alzheimer's therapies & AI-powered diagnostics.
United States of America
IGC
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea
249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea
003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea
007570
I-Mab Logo
A clinical-stage biopharma developing immuno-oncology agents and bispecific antibodies for cancer.
United States of America
IMAB
ImageneBio, Inc. Logo
A clinical-stage biopharma pioneering therapies for immune & inflammatory diseases.
United States of America
IMA
IM Cannabis Corp. Logo
International producer of medical-grade cannabis for patients and providers in Israel and Germany.
United States of America
IMCC
Immatics N.V. Logo
Develops T-cell redirecting immunotherapies (ACT & TCR Bispecifics) for solid tumor cancers.
United States of America
IMTX
Immix Biopharma, Inc. Logo
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX
IMMUCELL CORP /DE/ Logo
Develops biotech health products for disease prevention in dairy and beef cattle.
United States of America
ICCC

Talk to a Data Expert

Have a question? We'll get back to you promptly.